DVA · NYQ · Healthcare
DaVita Inc.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 316.65
Market price
USD 185.74
Implied upside
+70.5%
10-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · Price 2026-11-02 · Accounts to 2025-12-31
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 | FY32 | FY33 | FY34 | FY35 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | USD 14.2bn | USD 14.7bn | USD 15.3bn | USD 15.9bn | USD 16.5bn | USD 17.0bn | USD 17.5bn | USD 18.1bn | USD 18.5bn | USD 19.0bn | +3.3% |
| EBIT | USD 1.9bn | USD 2.0bn | USD 2.1bn | USD 2.2bn | USD 2.2bn | USD 2.3bn | USD 2.4bn | USD 2.5bn | USD 2.5bn | USD 2.6bn | +3.3% |
| NOPAT | USD 1.6bn | USD 1.6bn | USD 1.7bn | USD 1.7bn | USD 1.8bn | USD 1.9bn | USD 1.9bn | USD 2.0bn | USD 2.0bn | USD 2.1bn | +3.3% |
| Add depreciation & amortisation | USD 826.2m | USD 860.5m | USD 894.5m | USD 927.9m | USD 960.7m | USD 992.7m | USD 1.0bn | USD 1.1bn | USD 1.1bn | USD 1.1bn | +3.3% |
| Less capital expenditure | USD -652.4m | USD -729.4m | USD -810.2m | USD -894.4m | USD -981.8m | USD -1.1bn | USD -1.2bn | USD -1.3bn | USD -1.4bn | USD -1.5bn | +9.3% |
| Capex, % of revenue | 4.6% | 4.9% | 5.3% | 5.6% | 6.0% | 6.3% | 6.6% | 7.0% | 7.3% | 7.7% | - |
| Less increase in working capital | USD -70.3m | USD -80.3m | USD -79.5m | USD -78.3m | USD -76.7m | USD -74.8m | USD -72.5m | USD -69.8m | USD -66.7m | USD -63.3m | -1.2% |
| Free cashflow to firm | USD 1.7bn | USD 1.7bn | USD 1.7bn | USD 1.7bn | USD 1.7bn | USD 1.7bn | USD 1.7bn | USD 1.7bn | USD 1.7bn | USD 1.7bn | +0.1% |
| Discount factor | 0.9686 | 0.9087 | 0.8526 | 0.7999 | 0.7505 | 0.7041 | 0.6606 | 0.6197 | 0.5814 | 0.5455 | - |
| Present value | USD 1.6bn | USD 1.5bn | USD 1.4bn | USD 1.4bn | USD 1.3bn | USD 1.2bn | USD 1.1bn | USD 1.1bn | USD 981.9m | USD 911.9m | - |
| Present Value Of The Forecast | USD 12.5bn | ||||||||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.89% | US 10-year Treasury (^TNX), 2026-11-02 |
| Equity risk premium | 4.23% | Damodaran, January 2026 |
| Beta | 0.905 | Reported 0.858, pulled toward 1.0 (Blume) |
| Cost of equity | 8.72% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.78% | Risk-free + 89bp, the spread for a A- rating at 3.5x interest cover. Book interest / average debt was lower, at 4.7%. |
| Market capitalisation | USD 11.7bn | 47.6% of capital |
| Total debt | USD 12.9bn | 52.4% of capital, book value as a proxy |
| Tax rate | 19.6% | Effective, capped at statutory |
| WACC | 6.59% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
66% of EV
- Forecast FCFF, final year
- USD 1.7bn
- Capex at depreciation, working capital in reinvestment
- USD 2.1bn
- Less reinvestment at g/ROIC (16.6% of NOPAT)
- USD -346.3m
- Capitalised
- USD 1.7bn
- ROIC (reported)
- 15.0%
- Terminal value, undiscounted
- USD 43.5bn
- Terminal value, discounted
- USD 23.7bn
- Enterprise value
- USD 36.2bn
- Less net debt
- USD 12.2bn
- Equity value
- USD 24.0bn
Exit at 8.8x EBITDA
59% of EV
- Terminal value, undiscounted
- USD 32.4bn
- Terminal value, discounted
- USD 17.7bn
- Enterprise value
- USD 30.1bn
- Less net debt
- USD 12.2bn
- Equity value
- USD 17.9bn
Spread between methods: 29%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.59% | 555.06 | 634.00 | 751.98 | 945.88 | 1320.45 |
| 5.59% | 382.67 | 417.31 | 463.93 | 529.49 | 627.60 |
| 6.59% | 278.07 | 295.01 | 316.65 | 344.94 | 383.13 |
| 7.59% | 207.83 | 216.43 | 227.13 | 240.63 | 257.96 |
| 8.59% | 157.41 | 161.65 | 166.92 | 173.49 | 181.74 |
Outlined: this model. Green text: above today's price of 185.74. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Actual | Model | Implied | Gap |
|---|---|---|---|---|
| Revenue growth, a year | 5.5% | 3.4% | -0.6% | |
| EBIT margin | 15.3% | 13.6% | 9.9% | |
| Discount rate | - | 6.6% | 8.2% |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.